Development of a microfluidic approach for the real-time analysis of extrinsic TGF-β signalling.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
29 10 2020
Historique:
received: 28 07 2020
accepted: 29 07 2020
pubmed: 23 8 2020
medline: 18 3 2021
entrez: 23 8 2020
Statut: ppublish

Résumé

Autocrine and paracrine signalling are traditionally difficult to study due to the sub-micromolar concentrations involved. This has proven to be especially limiting in the study of embryonic stem cells that rely on such signalling for viability, self-renewal, and proliferation. Microfluidics allows to achieve local concentrations of ligands representative of the in vivo stem cell niche, gaining more precise control over the cell microenvironment, as well as to manipulate ligands availability with high temporal resolution and minimal amount of reagents. Here we developed a microfluidics-based system for monitoring the dynamics of TGF-β pathway activity by means of a SMAD2/3-dependent luciferase reporter. We first validated our system by showing dose-dependent transcriptional activation. We then tested the effects of pulsatile stimulation and delayed inhibition of TGF-β activity on signalling dynamics. Finally, we show that our microfluidic system, unlike conventional culture systems, can detect TGF-β ligands secreted in the conditioned medium from hESCs.

Identifiants

pubmed: 32826061
pii: S0006-291X(20)31538-2
doi: 10.1016/j.bbrc.2020.07.137
pii:
doi:

Substances chimiques

Culture Media, Conditioned 0
Ligands 0
SMAD2 protein, human 0
SMAD3 protein, human 0
Smad2 Protein 0
Smad3 Protein 0
TGFB1 protein, human 0
Transforming Growth Factor beta 0
Transforming Growth Factor beta1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-39

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michielin F (M)

Department of Industrial Engineering, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova, Italy; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Vetralla M (V)

Department of Industrial Engineering, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Bolego C (B)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy.

Gagliano O (G)

Department of Industrial Engineering, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova, Italy.

Montagner M (M)

Department of Molecular Medicine, University of Padova, Italy.

Elvassore N (E)

Department of Industrial Engineering, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova, Italy; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; Shanghai Institute for Advanced Immunochemical Studies (SIAIS), ShanghaiTech University, Shanghai, China. Electronic address: nicola.elvassore@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH